Assessment of tumor control probability for high-dose-rate interstitial brachytherapy implants

Reports of Practical Oncology and Radiotherapy

Volumn 13, Issue 2, 2008, Pages 74-77

  Kehwar, Than S ^a   Akber, Syed F ^b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biologically effective equivalent uniform dose; Geometric optimization of volume; HDR interstitial implants; Non optimization; Quality indices

Indexed keywords

ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CELL COUNT; CONTROLLED STUDY; DISEASE SEVERITY; DOSIMETRY; MATHEMATICAL ANALYSIS; MATHEMATICAL COMPUTING; OUTCOME ASSESSMENT; PROBABILITY; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RECURRENCE RISK; TUMOR LOCALIZATION; TUMOR VOLUME; VOLUMETRY;

EID: 51349114684     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1507-1367(10)60085-5     Document Type: Article

References (9)

1. Webb S, Nahum AE. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol 1993; 38: 653-666.
2. Stavreva NA, Stavrev PV, Round WH. Comments on the article "A model for calculating tumour control probability in radiotherapy including the effect of inhomogeneous distributions of dose and clonogenic cell density". Phys Med Biol 1995; 40: 1735-1738.
3. Webb S, Evans PM, Swindell W, Deasy JO. A proof that uniform dose gives the greatest TCP for fixed integral dose in the planning target volume. Phys Med Biol 1994; 39: 2091-2098.
4. Meertens H, Borger J, Steggerda M, Blom A. Evaluation and optimization of interstitial brachytherapy dose distribution. In: Mould RF, Battermann JJ, Martinez AA, Speiser BL, eds. Brachytherapy from radium to optimization. Veenendaal, The Netherlands: Nucletron International; BV. 1994; 300-306.
5. Saw CB, Suntharalingam N, Wu A. Concept of dose nonuniformity in interstitial brachytherapy. Int J Radiat Oncol Biol Phys 1993; 26 (3): 519-27.
6. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989; 62: 679-694.
7. Vicini FA, Kestin LL, Edmundson GK, Jaffray DA, Wong JW, Kini VR, Chen PY, Martinez AA. Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer. Int J Radtiat Oncol Biol Phys 1999; 45: 803-810.
8. Nahum AE, Tait DM. Maximising control by customized dose prescription for pelvic tumours. In: Advanced Radiation Therapy: Tumour Response Monitoring and Treatment Planning. Ed. Breit A (Heidelberg: Springer) 1992; 425-431.
9. Visser AG, van den Aardweg GJMJ, Levendag PC. Pulse dose rate and fractionated high dose rate brachytherapy: Choice of brachytherapy schedules to replace low dose rate treatments. Int J Radtiat Oncol Biol Phys 1996; 34 (2): 497-505.